Facioscapulohumeral Dystrophy
- PMID: 27215221
- DOI: 10.1007/s11910-016-0667-0
Facioscapulohumeral Dystrophy
Abstract
Facioscapulohumeral muscular dystrophy (FSHD) is a clinically recognizable and relatively common muscular dystrophy. It is inherited mostly as an autosomal dominant disease or in a minority of cases, in a digenic pattern. The disease manifestation is variable and most likely dependent on genetic and epigenetic factors. We review the history, epidemiology, clinical presentation, and genetics of the disease, present the recently elucidated molecular pathogenesis, discuss the pathology and the possible consequence of the inflammation seen in the muscle biopsies, and consider future treatments.
Keywords: DUX4; Facioscapulohumeral dystrophy; Genetics; Muscular dystrophy; SCHMD1.
Similar articles
-
Facioscapulohumeral Muscular Dystrophy.Compr Physiol. 2017 Sep 12;7(4):1229-1279. doi: 10.1002/cphy.c160039. Compr Physiol. 2017. PMID: 28915324 Review.
-
Facioscapulohumeral muscular dystrophy.Neurotherapeutics. 2008 Oct;5(4):601-6. doi: 10.1016/j.nurt.2008.07.005. Neurotherapeutics. 2008. PMID: 19019312 Free PMC article. Review.
-
Muscle pathology from stochastic low level DUX4 expression in an FSHD mouse model.Nat Commun. 2017 Sep 15;8(1):550. doi: 10.1038/s41467-017-00730-1. Nat Commun. 2017. PMID: 28916757 Free PMC article.
-
Facioscapulohumeral dystrophy.Phys Ther. 2008 Jan;88(1):105-13. doi: 10.2522/ptj.20070104. Epub 2007 Nov 6. Phys Ther. 2008. PMID: 17986494 Review.
-
Facioscapulohumeral dystrophy: activating an early embryonic transcriptional program in human skeletal muscle.Hum Mol Genet. 2018 Aug 1;27(R2):R153-R162. doi: 10.1093/hmg/ddy162. Hum Mol Genet. 2018. PMID: 29718206 Free PMC article. Review.
Cited by
-
Sarcopenic Obesity in Facioscapulohumeral Muscular Dystrophy.Front Physiol. 2020 Aug 12;11:1008. doi: 10.3389/fphys.2020.01008. eCollection 2020. Front Physiol. 2020. PMID: 32903446 Free PMC article.
-
Prevalence and disease progression of genetically-confirmed facioscapulohumeral muscular dystrophy type 1 (FSHD1) in China between 2001 and 2020: a nationwide population-based study.Lancet Reg Health West Pac. 2021 Nov 22;18:100323. doi: 10.1016/j.lanwpc.2021.100323. eCollection 2022 Jan. Lancet Reg Health West Pac. 2021. PMID: 35024656 Free PMC article.
-
Pathomechanisms and biomarkers in facioscapulohumeral muscular dystrophy: roles of DUX4 and PAX7.EMBO Mol Med. 2021 Aug 9;13(8):e13695. doi: 10.15252/emmm.202013695. Epub 2021 Jun 21. EMBO Mol Med. 2021. PMID: 34151531 Free PMC article. Review.
-
Large family cohorts of lymphoblastoid cells provide a new cellular model for investigating facioscapulohumeral muscular dystrophy.Neuromuscul Disord. 2017 Mar;27(3):221-238. doi: 10.1016/j.nmd.2016.12.007. Epub 2016 Dec 23. Neuromuscul Disord. 2017. PMID: 28161093 Free PMC article.
-
Hypoxia enhances human myoblast differentiation: involvement of HIF1α and impact of DUX4, the FSHD causal gene.Skelet Muscle. 2023 Dec 16;13(1):21. doi: 10.1186/s13395-023-00330-2. Skelet Muscle. 2023. PMID: 38104132 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources